Valeant Senior Official Leaves Amid Allergan Takeover Battle - Presented by: The Aol. On Network

An executive vice-president of Valeant Pharmaceuticals International Inc will leave the company, even as the Canadian drugmaker fends off criticism about management turnover from its takeover target Allergan Inc . Valeant confirmed late on Friday after inquiries by Reuters, Executive vice-president and company group chairman Ryan Weldon will leave. Like Chief Executive Mike Pearson, Weldon previously worked for management consulting firm McKinsey & Co.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.425 0.52 ▼ 3.04%
FCX $ 16.7699 1.07 ▼ 6.00%
MU $ 17.89 0.43 ▼ 2.35%
SFUN $ 6.33 0.80 ▼ 11.22%
PBR $ 7.93 0.27 ▼ 3.29%
BABA $ 78.34 1.89 ▼ 2.36%
VALE $ 5.41 0.20 ▼ 3.57%
INTC $ 29.455 0.59 ▼ 1.95%

As of 7/7/2015, 11:58 AM